Le Lézard
Classified in: Health, Science and technology

LG CNS Strengthens Position in LTPAC with Patents for Point-of-Care Solution


GEORGETOWN, Texas, July 20, 2018 /PRNewswire-PRWeb/ -- LG CNS Healthcare Solutions, a leading EHR and technology provider in the long-term and post-acute care industry, has received two patents for progressive technology embedded in its Smart Point-of-Care Solution (POCS).

The Smart Point-of-Care Solution is the first fully-featured mobile platform developed for long-term and post-acute care settings, including assisted living and skilled nursing facilities, to empower caregivers to deliver accurate patient-centered care and communication within a facility.

The first patented technology, U.S. Pat. 9894503, covers a smart emergency call management routing system that identifies the emergency status of a call, who has placed the call and who has received the call.

The second patented technology, U.S. Pat. 9824234, covers data security technology to safeguard patient health information on the POCS network?not only the server database but also information stored on hand-held and mobile devices when disconnected from the network. The security protocols monitor for valid user access, connectivity and session timeouts, and alerting IT Administrators to unauthorized access attempts.

The technology allows authorized caregivers to have access to patient information at the point of care while preventing others from accessing patient information located on a POC device or data in transit.

"Our customers and their caregivers are the core of the long-term and post-acute care industry and providing them the appropriate digital health tools is essential to evolving our industry towards data-driven, risk-informed, patient-centered care," says Robert Choi, Chief Strategy Officer for LG CNS. "With our secure, smart mobile point-of-care solutions, we are creating unique data-collection opportunities in a critical part of the care continuum. Together with our Electronic Health Records platform, Interoperability Data Layer and Population Health Management solutions, we are partnering with innovative and forward-thinking organizations to collect, analyze and leverage a wealth of data into actionable insights which in turn will improve patient care and our industry beyond EHR and towards meaningful digital health."

With several other patents pending, LG CNS Healthcare Solutions continues to be the leading innovator in this sector.

About LG CNS Healthcare Solutions
LG CNS Healthcare Solutions, a global leader in healthcare technology, is pioneering solutions for the long-term and post-acute care continuum, with the most modern EHR suite, mobile point-of-care solution, integrated telehealth, population health, care management services and business intelligence platforms that empower the patient and care team. Led by a physician, the leadership team is comprised of experts with experience and deep knowledge across the continuum of care. Empowered by state-of-the-art smart technology, providers achieve the operational and population health outcomes necessary to succeed in today's complex healthcare environment. For more information, visit healthcare.lgcns.com.

 

SOURCE LG CNS Healthcare Solutions


These press releases may also interest you

at 06:15
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Exciting technical...

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...



News published on and distributed by: